ELI LILLY AND COMPANY

ELI LILLY AND COMPANY
World Rank (Jan-07-2022)
39
Market Cap (Jan-07-2022)
248.240 Billion USD
World Rank (Sep-01-2021)
40
Market Cap (Sep-01-2021)
247.070 Billion USD
World Rank (Jan-01-2021)
69
Market Cap (Jan-01-2021)
161.510 Billion USD
World Rank (Jan-2020)
82
Market Cap (Jan 1st 2020)
128.184 Billion USD
Annual Revenue in USD
28,318 Million USD
Annual Net Income in USD
5,581 Million USD
Annual Results for Year Ending
Dec-2021
Total Assets in USD
46,633 Million USD
Total Liabilities in USD
40,807 Million USD
Total Equity in USD
5,641 Million USD
Balance Sheet Summary for Period ending
Dec-2020
Headquarters Region / City
Indiana
Headquarters Country
USA
Headquarters Sub Region
Northern America
Headquarters Continent
Americas
Company Business
Healthcare
Pharmaceutical
Biotechnology
HealthCare Products
Healthcare Service
Technology
Stock Category
S&P 500
Stock Exchange
NYSE
Bovespa Brazil
Switzerland
EURONEXT
Company Rank in Country in 2022
Company Rank in USA in 2022 is 25
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 43
Rank in Country (Jan-2020)
Rank in USA in 2020 is 48
Number of Employees
35,000
Employee Count as on Date
As on 2021
Chairman
Juan R. Luciano
CEO:
David A. Ricks
Founders
Eli Lilly
Yahoo @ NYSE
Wikipedia
Twitter
Bloomberg
Facebook
Company Website:
Eli Lilly And Company - Pharmaceutical Company
Founded Year
1876
Business Sector:
Top Technology Companies in USA
Top Healthcare Companies in USA
Top Technology Companies in S&P 500
Top Healthcare Companies in S&P 500
Top Pharmaceutical Companies in USA
Top Pharmaceutical Companies in S&P 500
About Company Business:

Eli Lilly is a healthcare and pharmaceutical and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health.and Lilly unites caring with discovery to create medicines that make life better for people around the world. Eli Lilly has 33,815 employees as on 2019. Headquarters is in USA.

Three long-established core values guide Lilly :

  • Integrity.
  • Excellence.
  • Respect for People.

Facts About Lilly:

  • A heritage of more than 140 years: company founded on May 10, 1876

  • Headquarters located in Indianapolis, Indiana, U.S.A.

  • Approximately 33,000 employees worldwide

  • More than 7,800 employees engaged in research and development

  • Clinical research conducted in more than 55 countries

  • Research and development facilities located in 8 countries

  • Manufacturing plants located in 8 countries

  • Products marketed in 120 countries

Lilly operates in India through two business entities:

  • Lilly Pharma.
  • Lilly Capability Center India.

Eli Lilly annual revenue generated for period ending Dec-2021 was 28,318 million USD.

Eli Lilly annual net income generated for period ending Dec-2021 was 5,581 million USD.

Total Assets as on Dec-2021 was 46,633 Million USD

Annual Revenue
ELI LILLY AND COMPANY Annual Revenues for December-2020 ending is 24.53 Billion USD
Annual Operating Income
6.85 Billion USD for Year ending December-2020
Annual Net Income
ELI LILLY AND COMPANY Annual Net Income for December-2020 ending is 6.19 Billion USD
Total Current Assets
ELI LILLY AND COMPANY Total Current Assets as on June-2020 is 14,581 Million USD
Total Assets
ELI LILLY AND COMPANY Total Assets as on June-2020 is 41,967 Million USD
Total Current Liabilities
ELI LILLY AND COMPANY Total Current Liabilities as on June-2020 is 11,988 Million USD
Total Liabilities
ELI LILLY AND COMPANY Total Liabilities as on June-2020 is 37,695 Million USD
Total Equity
ELI LILLY AND COMPANY Total Equity as on June-2020 is 4,093 Million USD
Annual Results Summary:

Eli Lilly and Company - Annual Revenue and Net Profit - in Million USD:

Year - Ending Revenue Net Profit EPS (USD)
Dec-2021 28,318 5,581  
Dec-2020 24,539 6,193 6.47
Dec-2019 22,319 8,318 8.69
Dec-2018 24,555 3,232 3.14
Dec-2017 22,871 -204  (Loss) -0.19
Dec-2016 21,222 2,737 2.49
Balance Sheet Summary

Eli Lilly and Company - Balance Sheet Summary - in Million USD:

Year Ending: Total Assets Total Current Liabilities Total Liabilities Total Equity
Dec-2020 46,633 12,481 40,807 5,641
Dec-2019 39,286 11,775 36,587 2,607
Dec-2018 43,908 11,888 32,999 9,829
Dec-2017 44,981 14,536 33,313 11,592
Dec-2016 38,806 10,987 24,725 14,008
Quarterly Results Summary:

Eli Lilly and Company - Quarterly Revenue and Net Profit - in Million USD:

Quarter - Ending Revenue Net Profit
Sep-2022 6,941 1,451
Jun-2022 6,488 952
Mar-2022 7,810 1,902
Dec-2021 7,999 1,726
Sep-2021 6,772 1,110
Jun-2021 6,740 1,390
Mar-2021 6,805 1,355
Dec-2020 7,440 2,116
Sep-2020 4,414 1,208
Jun-2020 4,277 1,412
Mar-2020 5,859 1,456
Dec-2019 6,114 1,495
Sep-2019 5,476 1,253
Jun-2019 5,636 1,327
Mar-2019 5,092 4,241
Dec-2018 6,438 1,125
Sep-2018 6,061 1,149
Institutional Investors

Top 30 Institutional Investors in ELI LILLY AND COMPANY as on JUN-30-2022

RANK INSTITUTIONAL HOLDER NAME DATE SHARES HELD CHANGE (SHARES) CHANGE (%) VALUE (IN 1,000S)
1 LILLY ENDOWMENT INC 6/30/2022 104,161,053 -1,993,133 -1.88% $32,234,721
2 VANGUARD GROUP INC 6/30/2022 71,591,327 1,110,149 1.58% $22,155,368
3 BLACKROCK INC. 6/30/2022 63,751,710 -244,609 -0.38% $19,729,242
4 PNC FINANCIAL SERVICES GROUP, INC. 6/30/2022 52,092,082 -53,782 -0.10% $16,120,937
5 STATE STREET CORP 6/30/2022 33,414,028 -339,894 -1.01% $10,340,639
6 FMR LLC 6/30/2022 32,439,666 898,976 2.85% $10,039,103
7 CAPITAL WORLD INVESTORS 6/30/2022 28,742,646 6,384,202 28.55% $8,894,987
8 PRIMECAP MANAGEMENT CO/CA/ 6/30/2022 28,438,488 -434,743 -1.51% $8,800,859
9 WELLINGTON MANAGEMENT GROUP LLP 6/30/2022 23,437,256 -3,786,064 -13.91% $7,253,128
10 PRICE T ROWE ASSOCIATES INC /MD/ 6/30/2022 20,426,658 -498,109 -2.38% $6,321,438
11 STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 6/30/2022 17,410,725 0 0% $5,388,097
12 GEODE CAPITAL MANAGEMENT, LLC 6/30/2022 15,717,311 405,075 2.65% $4,864,036
13 JPMORGAN CHASE & CO 6/30/2022 15,495,075 -801,157 -4.92% $4,795,261
14 NORTHERN TRUST CORP 6/30/2022 10,885,576 -382,159 -3.39% $3,368,759
15 JENNISON ASSOCIATES LLC 6/30/2022 10,358,066 2,456,760 31.09% $3,205,511
16 BANK OF AMERICA CORP /DE/ 6/30/2022 9,757,026 474,185 5.11% $3,019,507
17 BANK OF NEW YORK MELLON CORP 6/30/2022 9,725,888 486,011 5.26% $3,009,871
18 NORGES BANK 12/31/2021 8,014,500 -500,661 -5.88% $2,480,247
19 MORGAN STANLEY 6/30/2022 7,503,143 3,529,744 88.83% $2,321,998
20 AMERIPRISE FINANCIAL INC 6/30/2022 7,283,217 -1,168,986 -13.83% $2,253,937
21 LEGAL & GENERAL GROUP PLC 6/30/2022 6,240,308 -56,000 -0.89% $1,931,188
22 FISHER ASSET MANAGEMENT, LLC 6/30/2022 5,934,867 -1,569,338 -20.91% $1,836,663
23 NUVEEN ASSET MANAGEMENT, LLC 6/30/2022 5,178,339 99,705 1.96% $1,602,541
24 CAPITAL INTERNATIONAL INVESTORS 6/30/2022 4,961,985 -3,877,256 -43.86% $1,535,585
25 INVESCO LTD. 6/30/2022 4,798,357 6,419 0.13% $1,484,948
26 GOLDMAN SACHS GROUP INC 6/30/2022 4,674,544 180,850 4.03% $1,446,631
27 UBS ASSET MANAGEMENT AMERICAS INC 6/30/2022 4,187,045 -217,589 -4.94% $1,295,765
28 JANUS HENDERSON GROUP PLC 6/30/2022 3,932,655 -1,147,952 -22.60% $1,217,039
29 CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 6/30/2022 3,838,412 -92,126 -2.34% $1,187,873
30 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 6/30/2022 3,836,880 -32,394 -0.84% $1,187,399

Share it on Social Media